Target intelligence / Profile preview

Gut epithelial tight junction protein

Molecular classification
Other (multi-protein structural complex), Cell adhesion molecule
01

Overview

Gut epithelial tight junction proteins are a large family of transmembrane and cytoplasmic proteins that form the structural “tight junctions” at the apical part of epithelial cell membranes in the intestinal tract[2][4][5]. Major families of these proteins include occludin, claudins, junctional adhesion molecules (JAMs), and tricellulin (transmembrane components), and scaffolding proteins such as zonula occludens (ZO-1, ZO-2, ZO-3), cingulin, and afadin[1][4][5]. Tight junctions are essential for the selective permeability of the intestinal barrier, maintaining separation between the external environment and the body’s internal milieu[2][3]. Their dynamic regulation is critical for nutrient transport, maintaining immune homeostasis, and preventing pathogen and toxin entry. Alterations in tight junction proteins are associated with diseases such as IBD, metabolic syndrome, autoimmune diseases, and cancer[1][2][4]. Many interventions—pharmacological, dietary, or microbial—seek to modulate these proteins to restore barrier function in disease[1][5]. Key points: - “Gut epithelial tight junction proteins” refers to a group, not a single protein, so is not a canonical target name but a category; each protein (e.g., occludin, claudin-1) could be a distinct target[1][2][4]. - They are multi-protein complexes vital to epithelial barrier integrity. - Their dysfunction or modulation is both a therapeutic target and a disease biomarker[2][3][4][5].

Other names
Tight junction proteinIntestinal epithelial tight junction proteinTJ protein (general category, not specific to one protein)Intestinal tight junction
02

Mechanism of action

Modulation/restoration of tight junction protein assembly; Inhibition of tight junction disassembly; Reduction of paracellular permeability

03

Biological functions

Maintenance of epithelial barrier functionRegulation of intestinal permeabilityCell polaritySignal transductionImmune response
04

Disease associations

Inflammatory bowel disease (IBD)Autoimmune diseaseInfectionCancerMetabolic disease
05

Safety considerations

Compromising barrier function may result in increased intestinal permeability (“leaky gut”), predisposing to infection, inflammation, and systemic immune activationOver-tightening of barrier could impair nutrient and drug absorption
06

Interacting drugs

Larazotide acetate (targets tight junction modulation)

3 more in the full profile.

07

Biomarkers

Occludin expressionClaudin-1, Claudin-2, and Claudin-4 expression levelsZonula occludens-1 (ZO-1) localization/expression

Beyond the preview

Go deeper on Gut epithelial tight junction protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut epithelial tight junction protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call